Local 12: UC stroke study aims to give patients more treatment options
The University of Cincinnati's Pooja Khatri and Eva Mistry spoke with Local 12 about the SISTER trial that will test a new drug to treat patients with strokes who are not eligible to receive traditional treatments due to timing factors or risk of complications.
When patients are rushed to the emergency room after suffering a stroke, not all of them can be given the traditional intravenous stroke drugs known as TPA or TNK. The trial will test a new monoclonal antibody treatment for those patients that is designed to help dissolve blood clots and open arteries more effectively than the current drugs used to treat a stroke or injury to the brain.
“What this novel drug is doing is it’s working in a completely different mechanism. It allows the body’s natural ability to dissolve blood clots,” said Mistry, MBBS, assistant professor in the Department of Neurology and Rehabilitation Medicine in UC’s College of Medicine and a neurologist at the UC Gardner Neuroscience Institute.. “It has been shown that it is safer and more effective than the drugs that we currently use, the TPA and TNK.”
“There’s some reason to think it’s going to cause less inflammation in the brain and help protect the brain. So, we've got a lot of hope tied to this drug,” said Khatri, MD, associate director of the UC Gardner Neuroscience Institute, co-principal investigator of the National Coordinating Center for the NIH StrokeNet and professor and division chief in UC's Department of Neuroogy and Rehabilitation Medicine.
Read or watch the Local 12 story.
Featured photo at top of brain scans. Photo/Nur Ceren Demir/iStock.
Related Stories
Sugar overload killing hearts
November 10, 2025
Two in five people will be told they have diabetes during their lifetime. And people who have diabetes are twice as likely to develop heart disease. One of the deadliest dangers? Diabetic cardiomyopathy. But groundbreaking University of Cincinnati research hopes to stop and even reverse the damage before it’s too late.
Is going nuclear the solution to Ohio’s energy costs?
November 10, 2025
The Ohio Capital Journal recently reported that as energy prices continue to climb, economists are weighing the benefits of going nuclear to curb costs. The publication dove into a Scioto Analysis survey of 18 economists to weigh the pros and cons of nuclear energy. One economist featured was Iryna Topolyan, PhD, professor of economics at the Carl H. Lindner College of Business.
App turns smartwatch into detector of structural heart disease
November 10, 2025
An app that uses an AI model to read a single-lead ECG from a smartwatch can detect structural heart disease, researchers reported at the 2025 Scientific Sessions of the American Heart Association. Although the technology requires further validation, researchers said it could help improve the identification of patients with heart failure, valvular conditions and left ventricular hypertrophy before they become symptomatic, which could improve the prognosis for people with these conditions.